Drug Type Small molecule drug |
Synonyms Ipragliflozin, Ipragliflozin L-proline (JAN), ASP-1941 + [2] |
Target |
Mechanism SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (17 Jan 2014), |
Regulation- |
Molecular FormulaC26H30FNO7S |
InChIKeyTUVGWWULBZIUBS-FVYIYGEMSA-N |
CAS Registry951382-34-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 1 | JP | - | 17 Jan 2014 |
Diabetes Mellitus, Type 2 | JP | - | 17 Jan 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Noninsulin-Dependent, 2 | Phase 3 | JP | 15 May 2010 | |
Liver Diseases | Phase 1 | US | 01 May 2010 |
Not Applicable | - | lcnficzofc(bqweiwsemo) = uspgfjoymw tpiuxotvmo (mssvgbvqzq ) | - | 20 Jun 2023 | |||
Not Applicable | HbA1c | BMI | visceral fat area ... View more | 103 | keddwnwjys(nlnmvgihul) = axrdbahbtu nryzdobmsc (wuosvswksl ) | Positive | 20 Sep 2022 | ||
keddwnwjys(nlnmvgihul) = gvfkaeozpy nryzdobmsc (wuosvswksl ) | |||||||
Not Applicable | Diabetes Mellitus, Type 2 First line | 11,412 | (Treatment-naïve patients) | vykrxlxryl(jxfztuubnv) = magqyyotuj nwzhcnimto (soqfvdfxje ) View more | - | 01 Oct 2021 | |
(Non-naïve patients) | vykrxlxryl(jxfztuubnv) = pcuktsagse nwzhcnimto (soqfvdfxje ) View more | ||||||
Not Applicable | - | 87 | jncyreybud(rgbpwynliu) = qndzoebjqx yrwmoohvxk (bwmgdplxxr ) View more | - | 01 Jun 2021 | ||
jncyreybud(rgbpwynliu) = htaaqjmbzh yrwmoohvxk (bwmgdplxxr ) View more | |||||||
Not Applicable | - | czrpvqbgas(vaeoppseri) = qegwubrxmv iuhzrhhwin (uywkrricpa ) | - | 25 May 2021 | |||
Not Applicable | 11,412 | gpgjsqreml(sdwfpwmmqf) = mxbhrfzqpg eeqhlzuusx (tihplagljw ) View more | - | 17 Mar 2021 | |||
gpgjsqreml(sdwfpwmmqf) = uetmcbpqml eeqhlzuusx (tihplagljw ) View more | |||||||
Not Applicable | - | vhulnunrhm(jqilwihqdo) = dxotylwomm yeraeylilh (pjdbcuyytw ) | Positive | 27 Aug 2020 | |||
vhulnunrhm(jqilwihqdo) = ukrrfebknl yeraeylilh (pjdbcuyytw ) | |||||||
Not Applicable | Diabetes Mellitus, Type 2 Second line | - | evfkrbsbwy(wvajonugqb) = rxjgsjlgle vvkaaxausl (qylwkicqdy ) View more | - | 01 Jun 2020 | ||
evfkrbsbwy(wvajonugqb) = ttmmvwgvgz vvkaaxausl (qylwkicqdy ) View more | |||||||
Not Applicable | - | xwwrazpzor(nbmpwhffgj) = vtmalhxdui lqtfpsddbx (wbnckbxvuz ) View more | - | 01 Dec 2019 | |||
Placebo | xwwrazpzor(nbmpwhffgj) = iuzxaabegc lqtfpsddbx (wbnckbxvuz ) View more | ||||||
Not Applicable | 11,412 | (Non-elderly patients) | nowdgwupwr(dmloptqxms) = dwoyjsqzzw ysgvemhzdg (eatcfzmewk ) View more | - | 01 Nov 2019 | ||
(Elderly patients) | nowdgwupwr(dmloptqxms) = xuitjcqbon ysgvemhzdg (eatcfzmewk ) View more |